Integrated BioPharma, Inc.
Integrated BioPharma, Inc. (INBP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · INBP · as of Sep 30, 2025
Ownership Breakdown
1
Institutional Holders
$5,800
Total Inst. Value
▼ $1,340 vs Q2
31.06M
Shares Outstanding
freeFloat 30.07%
20,000
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
INBP largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MOLONEY SECURITIES ASSET MANAGEMENT, LLC pharmaceutical preparations | 20.0K | 6.53% | 6.53% | $5.80M | Nov 5, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
INBP insider trading · insider activity
Source: SEC Form 4
2
Buy transactions
4
Sell transactions
0.50
Buy/Sell ratio
$22M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Milmoe William H. director | Apr 15, 2026 | Gift | 8,966,547 | — | — | 2.37M | Form 4 ↗ |
Milmoe William H. director | Apr 15, 2026 | Gift | 2,235,417 | — | — | 138.7K | Form 4 ↗ |
DESANTIS CARL 10 percent owner | Apr 15, 2026 | Gift | 8,966,547 | — | — | 2.24M | Form 4 ↗ |
DESANTIS CARL 10 percent owner | Apr 15, 2026 | Gift | 2,235,417 | — | — | 0 | Form 4 ↗ |
DeSantis Damon
| Apr 15, 2026 | Gift | 2,235,417 | — | — | 12.73M | Form 4 ↗ |
DeSantis Damon
| Apr 15, 2026 | Gift | 8,966,547 | — | — | 10.50M | Form 4 ↗ |
DESANTIS CARL 10 percent owner | Mar 24, 2026 | Gift | 1,356,293 | — | — | 11.37M | Form 4 ↗ |
DESANTIS CARL 10 percent owner | Mar 24, 2026 | Gift | 7,392 | — | — | 11.37M | Form 4 ↗ |
Milmoe William H.
| Mar 24, 2026 | Gift | 1,356,293 | — | — | 11.51M | Form 4 ↗ |
Milmoe William H.
| Mar 24, 2026 | Gift | 7,392 | — | — | 11.51M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Integrated BioPharma, Inc. (INBP) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 69.93%, while retail and public investors account for the remaining 30.01%.
The largest institutional shareholder of Integrated BioPharma, Inc. is MOLONEY SECURITIES ASSET MANAGEMENT, LLC, holding approximately 20,000 shares — equal to 6.53% of outstanding shares — as of September 30, 2025.
A total of 1 institutional investors currently hold INBP stock, with a combined institutional value of approximately $5,800 as of the most recent 13F filing period.
Frequently asked questions
INBP ownershipIntegrated BioPharma, Inc. (INBP) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is MOLONEY SECURITIES ASSET MANAGEMENT, LLC with a 6.53% stake. Company insiders hold 69.93%. Data sourced from SEC Form 13F as of September 30, 2025.